ArticleScientific reports2026
A novel diagnosis method based on multimodal-aware bi-objective competitive mechanism for Alzheimer's disease.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Alzheimer's disease (AD) is one of the most prevalent neurodegenerative disorders. Recent statistical surveys and studies indicate that AD is poised to become a major global health burden in the coming decades. Among current strategies, leveraging multimodal imaging data for early diagnosis and classification of AD has emerged as a promising approach. However, most existing methods primarily focus only on improving classification accuracy, while overlooking the importance of extracted imaging features and the underlying relationships among them. In this study, we propose a novel Multimodal-Aware Bi-Objective Competitive Mechanism Estimation of Distribution Algorithm (MABOC-EDA). The proposed MABOC-EDA incorporates both the individual significance of imaging features and their inter-modality interactions during the evolutionary process, two data structures were employed to represent them, which were updated according to a predefined update strategy. These structures were then used to construct a probabilistic model, from which the optimal feature subset was derived. The proposed method achieved classification accuracies and area under the ROC curve of 95.74%/97.25%,87.23%/89.93%, and 86.54%/88.76% for the AD vs. CN, AD vs. MCI, and CN vs. MCI classification tasks, respectively. Moreover, the brain regions that contribute most significantly to classification and those exhibiting strong correlations in the context of AD diagnosis. The correlated brain regions identified by proposed method provide insights that may facilitate the discovery of complementary biomarkers across different imaging modalities.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.